CHI3L1 and lymphoma: However, our analysis revealed no correlation between YKL-40 level and various clinical variables, including signalment, substage, immunophenotype, progression-free survival (PFS), or overall survival (OS), suggesting a complex relationship between YKL-40 expression and the pathogenesis of multicentric lymphoma.